Fred A. Weaver, MD

Professor of Surgery

Division Chief, Vascular Surgery

Image of Fred A. Weaver, MD
Is this your profile? Click to edit

Overview

Dr. Fred Arthur Weaver is a Professor of Surgery at Keck School of Medicine of the University of Southern California. Dr. Weaver received his B.S. and M.D. degrees from USC and his
General and Vascular Surgery training at Vanderbilt University Medical Center. At USC, he has served as Program Director for General Surgery, and later for Vascular Surgery.

Dr. Weaver received his Masters in Medical Management from USC in 2005. He is Chief of the Division of Vascular Surgery and Endovascular Therapy, Chief of Vascular Surgery at Keck Hospital of USC, and Co-Director of the USC CardioVascular Thoracic Institute. He is certified by the American Board of Surgery in General and in Vascular Surgery. Dr. Weaver is past President of the Western Vascular Society, Pacific Coast Surgical Association, and Society of Clinical Vascular Surgery. In 2015, he received the Society for Vascular Surgery Presidential Citation Award.

Dr. Weaver is an Associate Editor for the Journal of Vascular Surgery, on the Editorial Board of the Annals of Vascular Surgery, and serves as the Chair of the Society for Vascular Surgery/Vascular Quality Initiative. He has been recognized as a Top, Best, or Super Doctor by various local and national publications. He has published over 200 articles and 43 textbook chapters, and has been
an invited speaker at numerous regional, national, and international meetings. His major clinical and research interests concern the diagnosis and management of diseases affecting the aorta and its major branches.

Publications

  • Risk factors for stroke in penetrating cerebrovascular injuries. J Vasc Surg. 2024 10; 80(4):1064-1070.. View in PubMed
  • Five-year outcomes of endovascular treatment for aortic dissection from the Global Registry for Endovascular Aortic Treatment. J Vasc Surg. 2024 10; 80(4):1035-1044.. View in PubMed
  • Spinal cord ischemia and reinterventions following thoracic endovascular repair for acute type B aortic dissections. J Vasc Surg. 2024 09; 80(3):656-664.. View in PubMed
  • Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes. Eur J Heart Fail. 2024 Apr; 26(4):1051-1061.. View in PubMed
  • Endovascular treatment for thoracic aortic disease from the Global Registry for Endovascular Aortic Treatment. J Vasc Surg. 2024 05; 79(5):1044-1056.e1.. View in PubMed
  • Prospective assessment of dynamic changes in frailty and its impact on early clinical outcomes following physician-modified fenestrated-branched endovascular repair of complex abdominal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2024 03; 79(3):506-513.e1.. View in PubMed
  • Epidemiology, repair technique, and predictors of stroke and mortality in penetrating carotid artery injuries. J Vasc Surg. 2023 10; 78(4):920-928.. View in PubMed
  • Risk Factors for Cerebral Hyperperfusion Syndrome following Carotid Revascularization. Ann Vasc Surg. 2023 Nov; 97:89-96.. View in PubMed
  • Comparative outcomes of physician-modified fenestrated-branched endovascular repair of post-dissection and degenerative complex abdominal or thoracoabdominal aortic aneurysms. J Vasc Surg. 2023 09; 78(3):565-574.e2.. View in PubMed
  • Risk of Stroke with Thoracic Endovascular Aortic Repair of the Aortic Arch. Ann Vasc Surg. 2023 Nov; 97:37-48.. View in PubMed